Cogent Biosciences IncChange company Symbol lookupSelect an option...COGT Cogent Biosciences IncEBET Ebet IncPDI PIMCO Dynamic Income FundBXRX Baudax Bio IncBAC Bank of America CorpSPRU Spruce Power Holding CorpSRNEQ Sorrento Therapeutics IncSPI SPI Energy Co LtdAMC AMC Entertainment Holdings IncBOF BranchOut Food IncGo
Cogent Biosciences, Inc. is a biotechnology company that is focused on developing precision therapies for genetically defined diseases. The Company’s advanced clinical program, bezuclastinib (CGT9486), is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17 found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. In addition to bezuclastinib, the Company is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases. The Company has initiated APEX, a Phase II clinical study of bezuclastinib in patients with AdvSM. APEX is an open-label, global, multicenter study evaluating the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| August 8, 2023 | Q2 2023 Earnings Release | -$0.59 | -$0.64 to -$0.45 | -$0.71 |
| May 9, 2023 | Q1 2023 Earnings Release | -$0.54 | -$0.67 to -$0.45 | -$0.68 |
| March 14, 2023 | Q4 2022 Earnings Release | -$0.56 | -$0.58 to -$0.40 | -$0.60 |
| November 14, 2022 | Q3 2022 Earnings Release | -$0.50 | -$0.58 to -$0.39 | -$0.48 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.